These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 19508664

  • 1. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM.
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [Abstract] [Full Text] [Related]

  • 2. Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.
    Scalone L, Cesana G, Furneri G, Ciampichini R, Beck-Peccoz P, Chiodini V, Mangioni S, Orsi E, Fornari C, Mantovani LG.
    PLoS One; 2014 Sep; 9(12):e113741. PubMed ID: 25470484
    [Abstract] [Full Text] [Related]

  • 3. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J, Halinan S, Hines D, Delozier A, Perez M, Boye M, Boye KS, Blanchette CM.
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [Abstract] [Full Text] [Related]

  • 4. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
    Bächle CC, Holl RW, Straßburger K, Molz E, Chernyak N, Beyer P, Schimmel U, Rütschle H, Seidel J, Lepler R, Holder M, Rosenbauer J, Icks A, DPV Initiative, German BMBF Competence Network Diabetes Mellitus.
    Diabet Med; 2012 Oct; 29(10):1327-34. PubMed ID: 22417295
    [Abstract] [Full Text] [Related]

  • 5. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O, Wade R, Gu T, Bouchard JR, Aagren M, Luo W.
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [Abstract] [Full Text] [Related]

  • 6. Costs of diabetes and its complications in Poland.
    Leśniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M.
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [Abstract] [Full Text] [Related]

  • 7. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB.
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [Abstract] [Full Text] [Related]

  • 8. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005 Oct; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 9. Technology and the issue of cost/benefit in diabetes.
    Giannini C, Mohn A, Chiarelli F.
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [Abstract] [Full Text] [Related]

  • 10. [Cost of diabetes mellitus in Spain].
    González P, Faure E, Del Castillo A, Grupo de Trabajo para el Estudio del Coste de la Diabetes.
    Med Clin (Barc); 2006 Nov 25; 127(20):776-84. PubMed ID: 17198665
    [No Abstract] [Full Text] [Related]

  • 11. Costs of treatment and complications of adult type 1 diabetes.
    Franciosi M, Lucisano G, Amoretti R, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Vitacolonna E, Nicolucci A.
    Nutr Metab Cardiovasc Dis; 2013 Jul 25; 23(7):606-11. PubMed ID: 22749531
    [Abstract] [Full Text] [Related]

  • 12. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G, Picariello R, Petrelli A, Panero F, Costa G, Cavallo-Perin P, Demaria M, Gnavi R.
    Nutr Metab Cardiovasc Dis; 2012 Aug 25; 22(8):684-90. PubMed ID: 21907553
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B, Raccah D, Cadilhac M, Eschwège E.
    Diabetes Metab; 2005 Jun 25; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [Abstract] [Full Text] [Related]

  • 14. Economic impact of hypoglycemia on healthcare in Spain.
    Brito-Sanfiel M, Diago-Cabezudo J, Calderon A.
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec 25; 10(6):649-60. PubMed ID: 21155698
    [Abstract] [Full Text] [Related]

  • 15. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
    Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A.
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb 25; 13(1):123-30. PubMed ID: 23402452
    [Abstract] [Full Text] [Related]

  • 16. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.
    Clin Ther; 2007 Jun 25; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [Abstract] [Full Text] [Related]

  • 17. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L, Köster I, Hauner H.
    Med Klin (Munich); 2006 May 15; 101(5):384-93. PubMed ID: 16685485
    [Abstract] [Full Text] [Related]

  • 18. Estimated hospitalizations attributable to diabetes mellitus within the public healthcare system in Brazil from 2008 to 2010: study DIAPS 79.
    Rosa R, Nita ME, Rached R, Donato B, Rahal E.
    Rev Assoc Med Bras (1992); 2014 May 15; 60(3):222-30. PubMed ID: 25004267
    [Abstract] [Full Text] [Related]

  • 19. Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012.
    Bruno G, Pagano E, Rossi E, Cataudella S, De Rosa M, Marchesini G, Miccoli R, Vaccaro O, Bonora E.
    Nutr Metab Cardiovasc Dis; 2016 Dec 15; 26(12):1104-1111. PubMed ID: 27817991
    [Abstract] [Full Text] [Related]

  • 20. Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
    Gundgaard J, Christensen TE, Thomsen TL.
    Prim Care Diabetes; 2010 Oct 15; 4(3):165-72. PubMed ID: 20452847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.